1Aguayo A, Kantarjian H, Manshouri T et al. Angiogenesis in acute and chronic leukemias ant myelodysplastic syndromes[J]. Blood,2000 ;96: 2240-2245.
2Hauswirth AW, Gadner H, Chott A, et al. hmmunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category[J]. Am J Clin Pathol,2003,119:663-671.
3Bruserud O,Glenjen N, Ryningen A. Effects of angiogenie regulators on in vitro proliferation and cytokine secretion by native human acute myelogenous leukemia blasts [ J ]. Eur J Haematol,2003,71:9-17.
4Zachary I. Vascular endothelial growth factor[J]. Int J Bioebem Cell Biol, 1998,30:1169-1174.
5Ellis LM, Takahashi Y, Liu W,et al. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications[J]. Oncologist, 2000,5 ( suppl 1 ): 11-15.
6Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation[J].Nature, 2000,407:242-248.
7Giles FJ. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies[J].Oncologist,2001, ( suppl 5 ) :32-39.
8Gille H, Kowalski J, Li B,et al. Analysis of biological effects and signaling properties of Flt-1 ( VEGFR-1 ) and KDR (VEGFR-2).A reassessment using novel receptor-specific vascular endothelial growth factor mutants [ J ]. Biol Chem, 2001,276:3222-3230.
10Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression[J]. Development ,2000,127: 3941-3946.
